Specialty chemicals maker Ami Organics IPO fully subscribed on Day 1

The initial public offer of specialty chemicals maker Ami Organics was fully subscribed within the first few hours on the opening day on Wednesday.

IPO, shares, company, firms, market
Press Trust of India New Delhi
2 min read Last Updated : Sep 01 2021 | 4:35 PM IST

Don't want to miss the best from Business Standard?

The initial public offer of specialty chemicals maker Ami Organics was fully subscribed within the first few hours on the opening day on Wednesday.

The IPO received bids for 1,05,42,624 shares against 65,42,342 shares on offer, translating into 1.61 times subscription, as per data available with the NSE till 1500 hours.

The category for Qualified Institutional Buyers (QIBs) was subscribed 1.39 times, non-institutional investors 32 per cent and Retail Individual Investors (RIIs) 2.29 times.

The company's initial public offer (IPO) has a fresh issue of up to Rs 200 crore and an offer for sale of up to 60,59,600 equity shares. Its price range is at Rs 603-610 per share.

Ami Organics on Tuesday collected Rs 171 crore from anchor investors.

At the upper end of the price band, the three-day initial share sale is expected to fetch Rs 569.63 crore.

Proceeds from the fresh issue will be used towards repayment of certain debt and funding working capital requirements.

Ami Organics is one of the leading R&D driven manufacturers of specialty chemicals with varied end usage, focussed towards the development and manufacturing of pharma intermediates for regulated and generic APIs (active pharmaceutical ingredients) and NCE (new chemical entity) and key starting material for agrochemicals and fine chemicals.

The equity shares of the company will be listed on BSE and NSE.

This is the company's second attempt to go public.

Earlier, Ami Organics had filed preliminary papers with Sebi in 2018 and had received the regulator's nod to launch the public issue. However, it did not float the IPO.

Intensive Fiscal Services, Ambit Private Limited and Axis Capital are the managers to the offer.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Specialty chemicalsinitial public offerings IPOs

First Published: Sep 01 2021 | 4:35 PM IST

Next Story